GSK3B and breast cancer: Thus, in the present study, the antitumor mechanism of Moracin D was elucidated in breast cancer cells in association with FOXM1 and β-Catenin/GSK3β signaling with the possibility of a potent pharmaceutical for future agricultural commercialization.